semaglutide brand FDA Warns on Certain Forms of Compounded brands of semaglutide ๐ข FDA
Description
Compounded semaglutide, for one, isnt user-intuitive, requiring patients to draw up doses in vials rather than use pre-filled pens
10.1038/npp.2016.246 [DOI] [PMC free article] [PubMed] [Google Scholar] Alhadeff, A

ncbi.nlm.nih.gov/pmc/articles/PMC3474631/ #21

DCA Managing Director, Rob Woolston said we had a great time celebrating this win with our colleagues from Sanofi and we are extremely pleased that this distinctive design, which was only launched this year, has already won these major awards. A recent press release from Sanofi states: With the European approval of Lyxumia, we now have a simple new tool to help patients with type 2 diabetes further reduce HbA1c, with the benefit of weight loss and limited risk of hypoglycaemia
Understanding Beyond-Use Dates (BUD) The Beyond-Use Date (BUD) is the final date that a compounded medication remains safe and effective
